Treatments proved to have a therapeutic effect via suppression of the JAK/STAT pathway, thus reducing neuroinflammation and the degeneration of dopaminergic neurons in the PD rat model (Qin et al., 2016). This evidence concerns the gene SOAT1 and Parkinson disease.